SERUM SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR IN PATIENTS WITH DIABETIC KIDNEY DISEASE

被引：0
|
作者：
Lupusoru, Gabriela Elena [1 ,2 ]
Ailincai, Ioana-Georgiana [2 ]
Sorohan, Bogdan Marian [1 ,2 ]
Andronesi, Andreea Gabriella [1 ,2 ]
Lupusoru, Mircea [3 ]
Andronesi, Danut [4 ]
Manda, Dana [5 ]
Caragheorgheopol, Andra [5 ]
Ismail, Gener [1 ,2 ]
机构：
[1] Carol Davila Univ Med & Pharm, Nephrol Dept, Bucharest, Romania
[2] Fundeni Clin Inst, Nephrol Dept, Bucharest, Romania
[3] Carol Davila Univ Med & Pharm, Physiol Dept, Bucharest, Romania
[4] Fundeni Clin Inst, Gen Surg & Liver Transplant Dept, Bucharest, Romania
[5] CI Parhon Natl Inst Endocrinol, Res Dept, Bucharest, Romania
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2021年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
MO648
引用
收藏
页码：378 / 378
页数：1
相关论文
共 50 条
  • [41] Clinical value of soluble urokinase type plasminogen activator receptors in chronic kidney disease
    Ahmed, Reem M.
    Khalil, Mona A.
    Ibrahim, Amal H.
    Eid, Hanaa M.
    Abdelbasset, Walid Kamal
    Soliman, Gaber S.
    MEDICINE, 2019, 98 (38)
  • [42] Soluble urokinase-type plasminogen activator receptor and incident end-stage renal disease in Chinese patients with chronic kidney disease
    Lv, Li
    Wang, Fang
    Wu, Liang
    Wang, Jin-Wei
    Cui, Zhao
    Hayek, Salim S.
    Wei, Changli
    Reiser, Jochen
    He, Kevin
    Zhang, Luxia
    Chen, Min
    Zhao, Ming-Hui
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 (03) : 465 - 470
  • [43] SOLUBLE UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR (SUPAR) IS ASSOCIATED WITH KDIGO CHRONIC KIDNEY DISEASE STAGE IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE
    Yussef, Sarah Mohammed
    Ursli, Martin
    Rothschild, Inke
    Faraj-Allah, Ayah
    Koppensteiner, Renate
    Schernthaner, Gerit-Holger
    Hoebaus, Clemens
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 : 161 - 161
  • [44] Soluble urokinase Plasminogen Activator Receptor (suPAR) is associated with educational attainment in patients with coronary artery disease
    Fueller, D.
    Liu, C.
    Ko, Y. -A.
    Alkhoder, A.
    Desai, S. R.
    Almuwaqqat, Z.
    Patel, S. A.
    Ejaz, K.
    Kauser, T.
    Martini, A.
    Alvi, Z.
    Mehta, P. K.
    Sperling, L. S.
    Quyyumi, A. A.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [45] Soluble urokinase plasminogen activator receptor (suPAR) as a serum biomarker for patients undergoing resection of pancreatic adenocarcinoma.
    Loosen, Sven H.
    Binnebosel, Marcel
    Longerich, Thomas
    Trautwein, Christian
    Roderburg, Christoph
    Neumann, Ulf Peter
    Luedde, Tom
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [46] Serum soluble urokinase-type plasminogen activator receptor levels in male patients with acute exacerbation of schizophrenia
    Genc, Abdullah
    Kalelioglu, Tevfik
    Karamustafalioglu, Nesrin
    Tasdemir, Akif
    Genc, Esra Sena
    Akkus, Mustafa
    Emul, Murat
    PSYCHIATRY RESEARCH, 2016, 236 : 179 - 181
  • [47] Soluble urokinase plasminogen activator receptor (suPAR) promotes atherosclerosis
    Drueke, Tilman B.
    Massy, Ziad A.
    KIDNEY INTERNATIONAL, 2023, 103 (03) : 451 - 454
  • [48] Soluble urokinase plasminogen activator receptor in blood transfusion components
    Riisbro, R
    Brünner, N
    Christensen, IJ
    Nielsen, HJ
    TRANSFUSION MEDICINE, 2004, 14 (04) : 305 - 312
  • [49] Soluble urokinase plasminogen activator receptor and incidence of venous thromboembolism
    Engstrom, Gunnar
    Zoller, Bengt
    Svensson, Peter J.
    Melander, Olle
    Persson, Margaretha
    THROMBOSIS AND HAEMOSTASIS, 2016, 115 (03) : 657 - 662
  • [50] Soluble urokinase plasminogen activator receptor in type 1 diabetic children, relation to vascular complications
    Sherif, Eman Mounir
    Abd El Maksood, Abeer Ahmed
    Youssef, Omneya Ibrahim
    El-Din, Nouran Yousef Salah
    Khater, Ola Khaled Mohamed
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2019, 33 (09) : 628 - 633
12345